Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pharmacokinetics, Pharmacodynamics,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07010835
What this trial is testing

Study of YK012 in Moderate to Severe Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Excyte Biopharma Ltd 189
Testing effectiveness (Phase 2)Looking for participantsNCT06542250
What this trial is testing

Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.

Who this might be right for
B-cell Malignancies
AstraZeneca 174
Testing effectiveness (Phase 2)Study completedNCT00411424
What this trial is testing

Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Astellas Pharma Inc 54
Early research (Phase 1)Ended earlyNCT00707590
What this trial is testing

Safety Study to Evaluate BMS-767778 in Healthy Subjects and Subjects With Type 2 Diabetes Mellitus (T2DM)

Who this might be right for
Type 2 Diabetes Mellitus
Bristol-Myers Squibb 120
Early research (Phase 1)Study completedNCT04972188
What this trial is testing

A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in Healthy Volunteers

Who this might be right for
Healthy
Zydus Lifesciences Limited 18
Early research (Phase 1)WithdrawnNCT02671188
What this trial is testing

Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic Arthritis

Who this might be right for
Autoimmune Diseases
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT03157635
What this trial is testing

Study to Assess Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Healthy Volunteers and Participants With Paroxysmal Nocturnal Hemoglobinuria

Who this might be right for
Paroxysmal Hemoglobinuria, Nocturnal
Hoffmann-La Roche 59
Early research (Phase 1)Active Not RecruitingNCT05117476
What this trial is testing

CLN-619 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorNSCLC
Cullinan Therapeutics Inc. 440
Testing effectiveness (Phase 2)Study completedNCT01803074
What this trial is testing

Study to Evaluate a HIV Drug for the Treatment of HIV Infection

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 107
Early research (Phase 1)Study completedNCT06087913
What this trial is testing

Safety and PK Multi-dose Study of TAF/EVG Vaginal Insert

Who this might be right for
Safety Issues
Eastern Virginia Medical School 68
Very early researchWithdrawnNCT06866080
What this trial is testing

LCAR-AIO in Subjects With Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Autoimmune Diseases
Nanjing Legend Biotech Co.
Early research (Phase 1)Study completedNCT05110976
What this trial is testing

Investigate the Safety, Tolerability and Effects of AZD8630 in Healthy Subjects and Subjects With Asthma on Inhaled Corticosteroids and Long-acting Beta-agonists

Who this might be right for
Asthma
AstraZeneca 170
Early research (Phase 1)Study completedNCT04515576
What this trial is testing

LY3493269 in Participants With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Eli Lilly and Company 56
Early research (Phase 1)WithdrawnNCT04371640
What this trial is testing

Sirolimus in COVID-19 Phase 1

Who this might be right for
SARS-CoV-2Covid-19
Walter K. Kraft
Early research (Phase 1)Study completedNCT01789788
What this trial is testing

A Safety, Pharmacokinetics and Pharmacodynamics Study of RO6811135 in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus Type 2
Hoffmann-La Roche 56
Early research (Phase 1)Study completedNCT01343303
What this trial is testing

A Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JNJ-39439335 in Patients With Osteoarthritis

Who this might be right for
Osteoarthritis, Knee
Janssen Research & Development, LLC 43
Early research (Phase 1)Study completedNCT00880750
What this trial is testing

Pharmacodynamic Study of Two Lanthanum Carbonate Formulations in Healthy Adults

Who this might be right for
End Stage Renal Disease
Shire 72
Post-approval studies (Phase 4)Study completedNCT02730624
What this trial is testing

Piperacillin/Tazobactam in Critically Ill Patients With Severe Sepsis and Septic Shock

Who this might be right for
Early Phase of Severe Sepsis and Septic Shock
Sutep Jaruratanasirikul 50
Early research (Phase 1)Study completedNCT01399346
What this trial is testing

Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Medical University of Graz 12
Early research (Phase 1)Study completedNCT02071888
What this trial is testing

Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors

Who this might be right for
Non-Hodgkin's Lymphoma (NHL)Multiple MyelomaWaldenstrom's Macroglobulinemia (WM)+2 more
Calithera Biosciences, Inc 25
Next Page